KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $456,000 | -77.2% | 29,429 | -71.7% | 0.09% | -81.2% |
| Q4 2019 | $1,996,000 | +77.0% | 104,100 | -11.2% | 0.49% | +56.2% |
| Q3 2019 | $1,128,000 | -64.3% | 117,250 | -77.7% | 0.31% | -64.9% |
| Q2 2019 | $3,156,000 | +21.5% | 526,900 | +18.4% | 0.89% | +13.6% |
| Q1 2019 | $2,598,000 | -37.7% | 444,900 | 0.0% | 0.79% | -47.4% |
| Q4 2018 | $4,169,000 | -48.3% | 444,900 | -6.1% | 1.50% | -32.9% |
| Q3 2018 | $8,071,000 | +13.9% | 473,901 | +13.7% | 2.23% | +0.4% |
| Q2 2018 | $7,083,000 | – | 416,900 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |